Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$4.01 | -$3.39 | -$3.70 |
| Q2 2026 | 2 | -$3.07 | -$1.53 | -$2.30 |
| Q3 2026 | 2 | -$2.32 | -$1.54 | -$1.93 |
| Q4 2026 | 2 | -$2.38 | -$1.09 | -$1.74 |
| Q1 2027 | 1 | -$2.36 | -$2.19 | -$2.30 |
| Q2 2027 | 1 | -$1.92 | -$1.78 | -$1.87 |
| Q3 2027 | 1 | -$1.68 | -$1.56 | -$1.64 |
| Q4 2027 | 1 | -$1.13 | -$1.05 | -$1.11 |
Cardlytics Inc last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-2.58 earnings per share for the quarter, missing analysts' consensus estimates of $-2.3 by $0.28. The company had revenue of 36.88 M for the quarter and had revenue of 233.27 M for the year. Cardlytics Inc has generated $-20 earnings per share over the last year ($-19.5 diluted earnings per share) and currently has a price-to-earnings ratio of -0.2. Cardlytics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$2.30 | -$2.58 | -0.28 | $37.00 M | $36.88 M |
| 05/07/2026 | Q1 2026 | -$3.70 | -$0.80 | 2.9 | $37.20 M | $34.32 M |
| 03/04/2026 | Q4 2025 | -$2.07 | -$1.60 | 0.47 | $54.46 M | $56.10 M |
| 11/05/2025 | Q3 2025 | -$3.27 | -$13.60 | -10.33 | $54.54 M | $52.03 M |
| 08/06/2025 | Q2 2025 | -$1.60 | -$1.80 | -0.2 | $64.02 M | $63.25 M |
| 05/07/2025 | Q1 2025 | -$2.70 | -$2.60 | 0.1 | $58.01 M | $61.90 M |
| 03/12/2025 | Q4 2024 | -$0.52 | -$3.10 | -2.58 | $63.63 M | $74.00 M |
| 11/06/2024 | Q3 2024 | -$3.30 | -$29.00 | -25.7 | $57.77 M | $67.06 M |
| 08/07/2024 | Q2 2024 | N/A | -$0.87 | N/A | $75.39 M | $69.64 M |
| 05/08/2024 | Q1 2024 | N/A | -$5.60 | N/A | $71.69 M | $67.61 M |
| 03/14/2024 | Q4 2023 | -$0.23 | -$25.60 | -25.37 | $89.55 M | $89.17 M |
| 11/08/2023 | Q3 2023 | -$0.24 | -$6.30 | -6.06 | $80.05 M | $79.01 M |
| 08/01/2023 | Q2 2023 | N/A | -$6.70 | N/A | $69.11 M | $76.70 M |
| 05/04/2023 | Q1 2023 | -$0.79 | $9.80 | 10.59 | $65.06 M | $64.33 M |
| 03/01/2023 | Q4 2022 | -$0.72 | -$111.30 | -110.58 | $83.58 M | $82.50 M |
| 11/01/2022 | Q3 2022 | -$0.98 | $15.00 | 15.98 | $73.90 M | $72.71 M |
| 08/02/2022 | Q2 2022 | -$0.88 | -$37.50 | -36.62 | $76.05 M | $75.41 M |
| 05/02/2022 | Q1 2022 | -$0.92 | $27.90 | 28.82 | $64.66 M | $64.33 M |
| 03/01/2022 | Q4 2021 | -$0.82 | -$3.50 | -2.68 | $76.53 M | $90.05 M |
| 11/02/2021 | Q3 2021 | -$5.00 | -$13.50 | -8.5 | $62.09 M | $64.98 M |
The conference call for Cardlytics Inc's latest earnings report can be listened to online.
The conference call transcript for Cardlytics Inc's latest earnings report can be read online.
Cardlytics Inc (:CDLX) has a recorded annual revenue of $233.27 M.
Cardlytics Inc (:CDLX) has a recorded net income of $-103,488,000.Cardlytics Inc has generated $-19.5 earnings per share over the last four quarters.
Cardlytics Inc (:CDLX) has a price-to-earnings ratio of -0.2 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED